About Vela Diagnostics
Vela Diagnostics is a Healthcare company based in Singapore (Singapore) founded in 2011, and was acquired by Luye Medical in April 2016. Developer of integrated molecular solutions for the diagnosis of infectious diseases and cancer. Its chief executive, as recorded, is Sam Dajani. Vela Diagnostics offers products and services including SX101, SQ301, SA201, SARS-CoV-2 Test, and OncoKey. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is VELA DIAGNOSTICS HOLDING PTE. LTD.
Company details
Vela Diagnostics was founded in 2011 in Singapore and operates in the molecular diagnostics sector. Integrated solutions for diagnosing infectious diseases and cancer are provided through PCR and Next-Generation Sequencing platforms. Products such as the Sentosa SX101 instrument, Rotor-Gene Q system, labware, consumables, and PCR reagents are offered to support testing for infectious and oncologic targets. Operations focus on laboratory-based molecular testing worldwide.
- Latest Funding Round$225K (USD), Grant
Apr 2020
- InvestorsBARDA
& 1 more
- Acquired byLuye Medical
(Apr 2016)
Products & Services of Vela Diagnostics
Vela Diagnostics offers a comprehensive portfolio of products and services, including SX101, SQ301, SA201, SARS-CoV-2 Test, and OncoKey.
Instrument for next-generation sequencing and workflow automation
Device for NGS applications in laboratory testing
System for real-time PCR and sample analysis
Assay for detecting SARS-CoV-2 virus in samples
Panel for oncology genetic analysis and reporting
Apps and channels of Vela Diagnostics
its YouTube channel Vela Diagnostics (HQ) has 59 subscribers and 14 videos.
Videos from Vela Diagnostics
The most watched videos on Vela Diagnostics's YouTube channel, Vela Diagnostics (HQ) (59 subscribers). Click a video to play it here.
More on Vela Diagnostics (HQ).
Funding Insights of Vela Diagnostics
- Total Rounds 1
- Last Round Grant — $225,000
- First Round $225,000
(Apr 2020)
- Investors Count 1
All 1 funding rounds of Vela Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $225,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Vela Diagnostics
Vela Diagnostics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include BARDA and Luye Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BARDA is focused on developing medical countermeasures for public health security. | medicalcountermeasures.gov | United States | ||
| luyemedical.com |
Investor details for Vela Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vela Diagnostics
1 people are tracked at Vela Diagnostics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sam Dajani | CEO | Leadership |
Complete people profiles for Vela Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vela Diagnostics
3 dated milestones of Vela Diagnostics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Vela Diagnostics is founded.
- Exit Acquired by Luye Medical.
- Funding First funding round of $225K.
Web traffic of Vela Diagnostics
The website of Vela Diagnostics (veladx.com) receives about 2.2K visits a month.
- Monthly visits2.2K
Websites whose visitors overlap most with Vela Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
parseghian.org | parseghian.org | 100% | #6,358,886 | – | |
xlpresearchtrust.org | xlpresearchtrust.org | 100% | – | ||
| bioanalyt.com | 100% | 4.8K | #3,879,791 | View details | |
canavanresearch.org | canavanresearch.org | 99% | – | ||
diagnosticsplus.org | diagnosticsplus.org | 99% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Vela Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vela Diagnostics
Complete news archive for Vela Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vela Diagnostics
Vela Diagnostics was founded in 2011 and raised its 1st funding round 9 years after it was founded.
Vela Diagnostics is headquartered in Singapore, Singapore.
Sam Dajani is the CEO of Vela Diagnostics, as recorded in our data.
Vela Diagnostics was founded in 2011 in Singapore and operates in the molecular diagnostics sector. Integrated solutions for diagnosing infectious diseases and cancer are provided through PCR and Next-Generation Sequencing platforms. Products such as the Sentosa SX101 instrument, Rotor-Gene Q system, labware, consumables, and PCR reagents are offered to support testing for infectious and oncologic targets. Operations focus on laboratory-based molecular testing worldwide.
Vela Diagnostics offers SX101, SQ301, SA201, SARS-CoV-2 Test, and OncoKey.
Vela Diagnostics has 2 investors. Key investors include BARDA, and Luye Medical.
Vela Diagnostics operates through Vela Diagnostics Holding Pte. Ltd..
Yes. Vela Diagnostics was acquired by Luye Medical in April 2016.